Form 4: SANUWAVE Health CEO Acquires Stock Options Under 2024 Equity Incentive Plan

Morgan C. Frank, CEO of SANUWAVE Health, Inc., reports acquisition of stock options under the company's 2024 Equity Incentive Plan.

Summary

• Morgan C. Frank, the CEO of SANUWAVE Health, Inc., filed a Form 4 on February 19, 2025, reporting transactions related to the company's stock.
• On October 22, 2024, Frank acquired 138,874 non-qualified stock options and 21,126 incentive stock options, both with an exercise price of $14.20.
• These options were granted under the Issuer's 2024 Equity Incentive Plan.
• The options vest over three years in 12 equal quarterly installments.
• Following the reported transactions, Frank beneficially owns 138,874 non-qualified stock options and 160,000 incentive stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options to the CEO is a common practice and generally viewed as a positive sign of aligning management's interests with shareholders. The vesting schedule promotes long-term commitment.

Positives

• The CEO's acquisition of stock options aligns his interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CEO.

Industry Context

Stock option grants are a common form of executive compensation in the healthcare industry, aligning management's interests with shareholder value.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive sign of aligning management's interests with the company's long-term success.

Key Dates

Keywords

stock options, SANUWAVE Health, Form 4, Morgan C. Frank, Equity Incentive Plan, beneficial ownership, SNWV